AWM
GBT

Arbor Wealth Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Arbor Wealth Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,363
Closed -$138K – 243
2018
Q4 		$138K Buy
+3,363
New +$126K 0.12% 53

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Arbor Wealth Management's GBT Position: Q1 2019 in Review

Arbor Wealth Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2019, closing a stake of 3,363 shares — an estimated $138K sold.

Arbor Wealth Management first reported a position in GBT in Q4 2018 and held it in 1 quarter. The position peaked at $138K in Q4 2018. 201 funds tracked by Wall St. Rank hold GBT as of Q1 2019.

  • Arbor Wealth Management reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Arbor Wealth Management sold 3,363 Global Blood Therapeutics, Inc. shares in Q1 2019, an estimated $138K.
  • Arbor Wealth Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 1 quarter.
  • Arbor Wealth Management's Global Blood Therapeutics, Inc. position peaked at $138K in Q4 2018.
  • 201 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2019.

Based on Arbor Wealth Management's 13F filing for Q1 2019, filed 15 May 2019.